Conference Reports for NATAP

10th International Congress on Drug Therapy in HIV Infection Glasgow November 7-11, 2010 Back

Lersivirine: a new NNRTI active across HIV-1 subtypes with a unique resistance profile (activity vs etravirine resistance)       Reported by Jules Levin Glasgow 2010 Nov 7-11